Mthfr polymorphism and folic acid supplementation influence serum homocysteine levels in psoriatic patients treated with methotrexate

HIGHLIGHTS

  • who: Qi Zhang et al. from the Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China have published the article: MTHFR Polymorphism and Folic Acid Supplementation Influence Serum Homocysteine Levels in Psoriatic Patients Treated with Methotrexate, in the Journal: (JOURNAL)
  • what: The authors found that patients with the TT genotype showed significantly higher serum homocysteine levels before starting MTX therapy than patients with the wild-type (CC) or CT genotype. This study shows that the level of serum homocysteine might not only positively correlate psoriasis severity but also with the curative effect of MTX.
  •  

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?